Shares of Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) traded up 1.4% during trading on Wednesday . The company traded as high as $0.2028 and last traded at $0.2028. 2,919 shares changed hands during trading, a decline of 63% from the average session volume of 7,910 shares. The stock had previously closed at $0.20.
Guided Therapeutics Stock Performance
The firm has a market cap of $19.58 million, a P/E ratio of -5.07 and a beta of 0.74. The stock’s 50 day simple moving average is $0.21 and its 200 day simple moving average is $0.29.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
